Targeting the Human Epidermal Growth Factor Receptor 2 (HER2) in the Treatment of Breast Cancer: Recent Advances and Future Directions

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|2|2|111-116

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.2, Iss.2, 2007-05, pp. : 111-116

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of clinicopathological characteristics on the efficacy of neoadjuvant therapy in patients with human epidermal growth factor receptor‐2‐positive breast cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 4, 2018-02 ,pp. : 844-853

John Wiley & Sons Inc

Access to resources Recommend Favorite

Circulating human epidermal growth factor receptor 2 (HER2) is associated with hyperglycaemia and insulin resistance循环中的人类表皮生长因子受体2（HER2）与高血糖以及胰岛素抵抗有关

By  

JOURNAL OF DIABETES, Vol. 7, Iss. 3, 2015-05 ,pp. : 369-377

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Receptor in Colorectal Cancer: Advances and Controversies

By  

Oncology, Vol. 70, Iss. 3, 2006-07 ,pp. : 161-167

Karger

Access to resources Recommend Favorite

Hormonal Receptor, Human Epidermal Growth Factor Receptor-2, and Ki67 Discordance between Primary Breast Cancer and Paired Metastases: Clinical Impact

By  

Oncology, Vol. 84, Iss. 3, 2012-12 ,pp. : 150-157

Karger

Access to resources Recommend Favorite

Human Epidermal Growth Factor Receptor 2 (HER-2/neu)-Directed Therapy for Rare Metastatic Epithelial Tumors with HER-2 Amplification

By  

Case Reports in Oncology, Vol. 9, Iss. 2, 2016-06 ,pp. : 298-304

Karger

Access to resources Recommend Favorite